Web-Based Follow-Up Using Cellular Phone in Type 1 Diabetic Patients Under Insulin Pump Therapy : The PumpNet Study

Grenoble Alpes University Hospital Center (CHU)

Status and phase: Completed; Phase 3

Conditions: Type 1 Diabetes Mellitus

Treatments: Device: Telemonitoring of glucose values using GlucoNet device

Study type: Interventional

Funder types: Other

Identifiers

NCT00324584

DCIC 03 01

Details and patient eligibility

About

The purpose of this study is to determine if telecare using modern telecommunication devices can improve the metabolic control and the quality of life of type 1 diabetic patients.

Full description

We aim at comparing conventional follow-up of type 1 diabetic patients treated with continuous subcutaneous insulin infusion (CSII) (face-to-face visits) with an intensive coaching using the Web and the cellular phone network for data transmission and Short Message Service (SMS). This telecommunication device is called GlucoNet. The specific objectives are to measure the efficiency of GlucoNet in improving metabolic control, reducing health care costs and improving the quality of life of patients.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Type 1 diabetes mellitus
• Age ≥ 18
• HbA1c between 7.5 and 10%
• Treated with continuous subcutaneous insulin infusion for a minimum of 3 months

Exclusion criteria

• Unstabilized diabetic microangiopathy
• Ongoing pregnancy or planned pregnancy
• Unwilling to perform a minimum of 4 capillary blood tests per day
• Unable to use the GlucoNet device

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: None (Open label)